ArthNow Logo
ArthNow
•3 min read•
✦Reported by Business Line

DPIIT eyes Budget FY28 push to localise 100 import-heavy items - from pharma to machinery

DPIIT eyes Budget FY28 push to localise 100 import-heavy items - from pharma to machinery
Source: Business Line

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓The DPIIT plans to push for local production of 100 import-heavy items in the upcoming Budget FY2027-28.
  • ✓The government wants to reduce dependence on foreign goods like machinery and pharma.
  • ✓A source said, "A final call on incentives to promote production of the identified 100 items domestically is to be taken."

Story at a Glance

Category
Indian Markets
Reported By
Business Line
Reading Speed
3 Minute(s)
Market Focus
India Economy

Final call on incentives to promote domestic production, reduce import dependence to be taken by Finance Ministry

The government is weighing the option of providing targeted support measures in the upcoming Budget (FY2027-28) to scale up domestic production and check imports of about 100 critical products, including capital goods and intermediate components across key industries like chemicals, auto parts, defence and aerospace, electronics and construction equipment.

"The Department for Promotion of Industry and Internal Trade (DPIIT) has completed a joint exercise with line ministries and industry stakeholders on identifying high-import items where local manufacturing does not happen or is insufficient. It is likely to submit the final proposal to the Finance Ministry shortly," a source tracking the matter said.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Business Line

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.